2 comments, add yours

New Study, Presented at a Meeting of Breast Surgeons, Supports that Mammograms Save Lives of Women in Their 40s

The American Society of Breast Sur­geons held its 2011 annual meeting in D.C. from April 27 – May 1. Among the papers pre­sented was Abstract #1754: “Mam­mog­raphy in 40 Year Old Women: The Potential Impact of the U.S. Pre­ven­tative Ser­vices Task Force (USPSTF) Mam­mog­raphy Guide­lines.” You can find the press release, fol­lowed by the abstract, here. The main result was that screening women ages 40–49 by mam­mog­raphy was asso­ciated with finding smaller tumors, with less spread to the lymph nodes, than clinical breast exams alone, and this cor­re­lates with improved sur­vival at 5 years.

The study, put forth by a group at the Uni­versity of Missouri-​​Columbia in Columbia, MO, is  based on a 10-​​year ret­ro­spective chart review, from 1998 – 2008, of 1581 women treated for breast cancer at that insti­tution. In this author’s opinion, a ret­ro­spective, chart-​​review type analysis of a medical inter­vention is about as low as you can get on the quality-​​of-​​data scale in a medical study. And, as empha­sized by Dr. Otis Brawley, chief medical officer of the ACS as quoted in HeathDay’s report on the matter, these are ten­tative findings, pre­sented in abstract form at a meeting. He sug­gested that the 5-​​year follow-​​up is too short.

That said, I think the findings are sig­nif­icant and likely reflect what happens when mam­mog­raphy screening is done right, which is that it saves lives in women 40 and older.

The results focused on the 320 women – 20% of all those treated for breast cancer at the insti­tution – between the ages of 40 and 49 at the time of breast cancer diag­nosis. Among those, mam­mog­raphy detected the tumors in just under half (47%) of the cases; in 53%, there was a pal­pable mass – the “clinical detection” group. In those with cancers were detected by mam­mog­raphy, the average tumor size was 2 cm in diameter; in the clinical detection group, the average size was 3 cm. (From an oncologist’s per­spective that’s a huge dif­ference; for most breast cancer sub­types that 1 cm dif­ference in diameter por­tends a dis­tinct prog­nosis.) What’s more, the fre­quency of lymph node involvement in the clinical detection group was 56%, more than twice that in the mam­mog­raphy group (25%), another prognosis-​​changer. These findings were highly sig­nif­icant from a sta­tis­tical per­spective, with p-​​values <0.0001.

The researchers con­firmed that neg­ative lymph nodes and smaller tumors were asso­ciated with longer sur­vival. They esti­mated that disease-​​free sur­vival, at five years, was 94 percent for women under 50 who received mam­mo­grams and 78 percent for those who did not receive the screening exams. Five year overall sur­vival rates for each group were 97% and 78%, respectively.

These figures have huge impli­ca­tions, espe­cially if you mul­tiply the potential sur­vival benefit – on the order of 20 percent at 5 years, or greater, depending on how you look at it — across over some 21.5 million women in the U.S. between the ages of 40 and 50, approx­i­mately 1.5 in 1000 of whom will be found to have invasive BC per year.*

Reuters ran this story on April 29  as did HealthDay. Both ran quotes by Dr. Paul Dale, chief of sur­gical oncology at the Uni­versity of Mis­souri School of Med­icine and lead author of the abstract. The findings suggest that adherence to the updated U.S. Pre­ventive Service Task Force (USPSTF) guide­lines, which do not rec­ommend screening mam­mog­raphy for most women between the ages of 40 and 49, would lead to pre­ventable deaths.

One thing the author of ML learned this morning is that Dr. Vir­ginia Moyer, the new chair of the USPSTF and who is quoted in the HealthDay cov­erage, is a pedi­a­trician and pro­fessor with a public health degree.

*based on U.S. Census data of 2000 and SEER data inci­dence (BC, all races, by age) accessed 5/​2/​11

Related Posts:

2 comments to New Study, Presented at a Meeting of Breast Surgeons, Supports that Mammograms Save Lives of Women in Their 40s

  • Man

    Do mam­mo­grams save lives for women under 50? No. Why do you advocate for a solution with no ben­efits? Money? Impo­tence? Illusion of hope? Wouldn’t a transfer of resources to the fitness field from the medical field save thou­sands more at cheaper costs?

    • Dear Man, I advocate for mam­mog­raphy because in middle-​​aged women because it saves lives and, when done properly, doesn’t cost much directly or indi­rectly. In fact, if mam­mog­raphy finds cases that would oth­erwise be detected in late-​​stage, it might save money. Fitness is fine, too, but I don’t accept a zero sum in this dis­cussion of women’s health.

Leave a Reply